COMMONWEALTH EQUITY SERVICES, LLC Increases Stake in Eli Lilly and Company (LLY) by 17.4%
COMMONWEALTH EQUITY SERVICES, LLC, a registered investment adviser, increased its position in Eli Lilly and Company (NYSE:LLY) by 17.4% during Q3 2026, according to its most…
Eli Lilly and Company (NYSE:LLY) · position increase
Institution
COMMONWEALTH EQUITY SERVICES, LLC
Institution type
investment_adviser
Reporting period
Q3 2026
Shares
404,753
Position value
$468.3M
Position change
17.37%
At a glance
Key takeaways
01Commonwealth Equity Services increased its Eli Lilly stake by 17.4% in Q3 2026, purchasing 59,905 additional shares for a total position of 404,753 shares valued at $468.3 million.
02Eli Lilly stock trades at $1,435.12 with a $906.5 billion market capitalization as of the filing date.
03Institutional investors typically increase positions when they believe stocks have upside potential or company fundamentals have improved since initial purchase.
0413F filings reflect holdings at quarter-end and are filed up to 45 days later, so positions may have changed since disclosure.
Filing Details
COMMONWEALTH EQUITY SERVICES, LLC, a registered investment adviser, increased its position in Eli Lilly and Company (NYSE:LLY) by 17.4% during Q3 2026, according to its most recent 13F filing with the Securities and Exchange Commission.
The firm purchased an additional 59,905 shares of the Healthcare company, bringing its total holdings to 404,753 shares valued at approximately $468.3M as of the filing date.
Market Context
Eli Lilly and Company's stock currently trades at $1435.12 with a market capitalization of $906.5B.
An increase in an existing position suggests COMMONWEALTH EQUITY SERVICES, LLC has growing conviction in Eli Lilly and Company's trajectory. Institutional investors typically add to positions when they believe the stock still has upside relative to their price target, or when the company's fundamentals have improved since their initial purchase.
Healthcare stocks have attracted institutional attention as an aging population drives long-term demand. Eli Lilly and Company operates in a sector where regulatory developments and pipeline progress can significantly impact institutional positioning.
The size of this position — $468.3 million — places it among the more significant institutional holdings in Eli Lilly and Company. Large positions like this can influence trading dynamics and are closely watched by market participants tracking smart money flows.
Investors should note that 13F filings reflect holdings as of the end of the reporting quarter and are filed up to 45 days later. The position may have changed since the filing date. 13F data is most useful when analyzed alongside other signals such as insider transactions, analyst ratings, and fundamental trends.
A 13F filing is a quarterly SEC report required for institutional managers with over $100 million in assets. It discloses equity holdings, providing transparency into how firms like COMMONWEALTH EQUITY SERVICES, LLC position their portfolios.